Ekvira Formulations Private Limited

Manufactures and distributes chemicals for pharmaceutical and enzyme production.

2018 | Hyderabad, Telangana (India) | Active
Last Updated: December 21, 2024

Ekvira Formulations Profile

Key Indicators

  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 5.00 M
  • Company Age 6 Year, 9 Months
  • Last Filing with ROC 31 Mar 2020
  • Open Charges ₹ 8.70 M
  • Revenue Growth 2361.31%
  • Profit Growth 190.76%
  • Ebitda 488.83%
  • Net Worth 430.14%
  • Total Assets 60.57%

About Ekvira Formulations

Ekvira Formulations Private Limited (EFPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 May 2018 (Six years and nine months 13 days old ). Its registered office is in Hyderabad, Telangana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.

The company currently has active open charges totaling ₹8.70 M.

Manoher Monari and Madhavi Rao serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U74999TG2018PTC124483

  • Company No.

    124483

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    15 May 2018

  • Date of AGM

    24 Oct 2020

  • Date of Balance Sheet

    31 Mar 2020

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

Who are the key members and board of directors at Ekvira Formulations?

Executive Team (1)

NameDesignationAppointment DateStatus
Madhavi Rao Country flag representing In Managing Director15-May-2018Current

Board Members (1)

NameDesignationAppointment DateStatus
Manoher Monari Country flag representing In Director 15-May-2018Current

Financial Performance of Ekvira Formulations.

Ekvira Formulations Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 2361.31% increase. The company also saw a substantial improvement in profitability, with a 190.76% increase in profit. The company's net worth Soared by an impressive increase of 430.14%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
2361.31%
Revenue from Operations
2361.31%
Total Assets
60.57%
Profit or Loss
190.76%
Net Worth
430.14%
EBITDA
488.83%

What is the Ownership and Shareholding Structure of Ekvira Formulations?

In 2020, Ekvira Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹8.70 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • State Bank Of India : 0.87 Cr

Latest Charge Details

DateLenderAmountStatus
29 Aug 2019State Bank Of India₹8.70 MOpen

How Many Employees Work at Ekvira Formulations?

Unlock and access historical data on people associated with Ekvira Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ekvira Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ekvira Formulations's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Ekvira Formulations

Recent activity within the organization

  • Annual General Meeting

    Ekvira Formulations Private Limited last Annual general meeting of members was held on 24 Oct 2020 as per latest MCA records.

    24 Oct 2020

  • Charges

    A charge with State Bank Of India of Rs. 8.70 M registered on 29 Aug 2019 with Charge ID 100290978 was modified on 04 Sep 2020.

    04 Sep 2020

  • Balance Sheet

    Ekvira Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.

    31 Mar 2020

  • Charges

    A charge with State Bank Of India amounted to Rs. 8.70 M with Charge ID 100290978 was registered on 29 Aug 2019.

    29 Aug 2019

  • Director Appointment

    Manoher Rao Monari was appointed as a Director was appointed as a Director on 15 May 2018 & has been associated with this company since 6 years 9 months .

    15 May 2018

  • Director Appointment

    Madhavi Bhupal Rao was appointed as a Managing Director was appointed as a Managing Director on 15 May 2018 & has been associated with this company since 6 years 9 months .

    15 May 2018

Frequently asked questions

  • Ekvira Formulations Private Limited was incorporated on 15 May 2018.

  • The authorized share capital of Ekvira Formulations Private Limited is ₹ 5.00 M and paid-up capital is ₹ 5.00 M.

  • Currently 2 directors are associated with Ekvira Formulations Private Limited.

    • Manoher Rao Monari
    • Madhavi Bhupal Rao
  • As per Ministry of Corporate Affairs (Mca), the registered address of Ekvira Formulations Private Limited is H.No.152/B 1St Phase Allwyn Colony, Kukatpally India, Hyderabad, Telangana, 500072.

  • The corporate identification number (CIN) of Ekvira Formulations Private Limited is U74999TG2018PTC124483 and the company number is 124483 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2020, the revenue trend for Ekvira Formulations Private Limited has risen by 2361.31%.

  • The financial reports for the fiscal year 2020 indicates that The net worth of Ekvira Formulations Private Limited has experienced an upsurge of 430.14%.

  • As per the financial statements for fiscal Year 2020, The total open charges for Ekvira Formulations Private Limited amount to ₹ 8.70 M.

  • The most recent Balance Sheet for Ekvira Formulations Private Limited was filed with the ROC on 31 Mar 2020.

People also Viewed

Similar Companies Based on Drug Formulation & Development